BC
ELOS

Broadfin Capital’s Syneron Medical Ltd ELOS Stock Holding History

Broadfin Capital’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-870,013
Closed -$6.36M – 77
2016
Q1 		$6.36M Sell
870,013
-185,208
-18% -$1.33M 0.61% 44
2015
Q4 		$8.14M Hold
1,055,221
– – 0.5% 53
2015
Q3 		$7.54M Buy
1,055,221
+50,000
+5% +$480K 0.42% 57
2015
Q2 		$10.7M Hold
1,005,221
– – 0.57% 44
2015
Q1 		$12.4M Hold
1,005,221
– – 0.97% 27
2014
Q4 		$9.38M Hold
1,005,221
– – 0.82% 32
2014
Q3 		$10.1M Hold
1,005,221
– – 1.06% 31
2014
Q2 		$10.4M Hold
1,005,221
– – 1.01% 31
2014
Q1 		$12.5M Buy
1,005,221
+805,221
+403% +$9.54M 1.21% 30
2013
Q4 		$2.46M Buy
+200,000
New +$2.08M 0.32% 49

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Broadfin Capital's ELOS Position: Q2 2016 in Review

Broadfin Capital sold out of Syneron Medical Ltd (ELOS) in Q2 2016, closing a stake of 870,013 shares — an estimated $6.36M sold.

Broadfin Capital first reported a position in ELOS in Q4 2013 and held it in 10 quarters. The position peaked at $12.5M in Q1 2014. 65 funds tracked by Wall St. Rank hold ELOS as of Q2 2016.

  • Broadfin Capital reported no remaining Syneron Medical Ltd position as of Q2 2016 after selling out during the quarter.
  • Broadfin Capital sold 870,013 Syneron Medical Ltd shares in Q2 2016, an estimated $6.36M.
  • Broadfin Capital first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 10 quarters.
  • Broadfin Capital's Syneron Medical Ltd position peaked at $12.5M in Q1 2014.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2016.

Based on Broadfin Capital's 13F filing for Q2 2016, filed 15 Aug 2016.